<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">
<pmc-articleset><article xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article">
  <?properties open_access?>
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">Br J Cancer</journal-id>
      <journal-id journal-id-type="pmc">brjcancer</journal-id>
      <journal-title>British Journal of Cancer</journal-title>
      <issn pub-type="ppub">0007-0920</issn>
      <issn pub-type="epub">1532-1827</issn>
      <publisher>
        <publisher-name>Nature Publishing Group</publisher-name>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="pmid">9528843</article-id>
      <article-id pub-id-type="pmc">2150099</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Research Article</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Raltitrexed (Tomudex): an alternative drug for patients with colorectal cancer and 5-fluorouracil associated cardiotoxicity.</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>K&#xC3;&#xB6;hne</surname>
            <given-names>C. H.</given-names>
          </name>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Thuss-Patience</surname>
            <given-names>P.</given-names>
          </name>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Friedrich</surname>
            <given-names>M.</given-names>
          </name>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Daniel</surname>
            <given-names>P. T.</given-names>
          </name>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Kretzschmar</surname>
            <given-names>A.</given-names>
          </name>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Benter</surname>
            <given-names>T.</given-names>
          </name>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Bauer</surname>
            <given-names>B.</given-names>
          </name>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Dietz</surname>
            <given-names>R.</given-names>
          </name>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>D&#xC3;&#xB6;rken</surname>
            <given-names>B.</given-names>
          </name>
        </contrib>
      </contrib-group>
      <aff>Department of Haematology/Oncology and Tumor Immunology Robert-R&#xC3;&#xB6;ssle-Klinik, Virchow-Klinikum, Medizinische Fakult&#xC3;&#xA4;t Charite der Humboldt-Universit&#xC3;&#xA4;t zu Berlin, Germany.</aff>
      <pub-date pub-type="ppub">
        <month>3</month>
        <year>1998</year>
      </pub-date>
      <volume>77</volume>
      <issue>6</issue>
      <fpage>973</fpage>
      <lpage>977</lpage>
      <abstract>
        <p>Two patients with proven 5-fluorouracil (5-FU)-associated cardiotoxicity were treated with the specific thymidylate synthase inhibitor raltitrexed safely, without evidence of cardiotoxicity. Raltitrexed might be an alternative for patients with advanced colorectal cancer and 5-FU-associated cardiotoxicity. 5-FU cardiotoxicity is not due to the antineoplastic mechanisms via thymidilate synthase.</p>
        <sec sec-type="scanned-figures">
          <title>Images</title>
          <fig id="F1">
            <label>Figure 3</label>
            <graphic xlink:href="brjcancer00082-0124-a" xlink:role="974"/>
          </fig>
          <fig id="F2">
            <label>Figure 4</label>
            <graphic xlink:href="brjcancer00082-0124-b" xlink:role="974"/>
          </fig>
        </sec>
      </abstract>
    </article-meta>
  </front>
  <body>
    <supplementary-material content-type="scanned-pages">
      <graphic xlink:href="brjcancer00082-0123.tif" xlink:title="scanned-page" xlink:role="973" mimetype="image" mime-subtype="tiff"/>
      <graphic xlink:href="brjcancer00082-0124.tif" xlink:title="scanned-page" xlink:role="974" mimetype="image" mime-subtype="tiff"/>
      <graphic xlink:href="brjcancer00082-0125.tif" xlink:title="scanned-page" xlink:role="975" mimetype="image" mime-subtype="tiff"/>
      <graphic xlink:href="brjcancer00082-0126.tif" xlink:title="scanned-page" xlink:role="976" mimetype="image" mime-subtype="tiff"/>
      <graphic xlink:href="brjcancer00082-0127.tif" xlink:title="scanned-page" xlink:role="977" mimetype="image" mime-subtype="tiff"/>
    </supplementary-material>
  </body>
</article>
</pmc-articleset>
